Announced Sat, 25 Jul · 12:15 IST
Mercury Labs board clears Q1 FY27 results, clean auditor review
Results View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Mercury Laboratories board on July 25 2026 approved unaudited financial results for Q1 ended June 30 2026. Statutory auditors Naresh and Co issued an unqualified limited review report with no adverse comments. The company operates in a single segment Pharmaceuticals Products.
Likely market impact
Routine quarterly filing with no auditor qualifications. Investors should review attached results for revenue and profit trends.